SCHEMBL10088554

SCHEMBL10088554

CC(C)Oc1c(Cl)cc(CO)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 4/20 0.47
RORC P51449 2/20 0.47
CSNK2A1 P68400 2/20 0.43
GAA P10253 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
LMNA P02545 1/20 0.37
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.34
ACHE P22303 1/20 0.33
THRA P10827 3/20 0.33
ALDH1A1 P00352 2/20 0.33
TP53 P04637 1/20 0.33
ALOX12 P18054 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PNMT P11086 1/20 0.32
PLAU P00749 1/20 0.32
PPARA Q07869 1/20 0.32
GRIN2D O15399 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10310543 0.80 RORC (0.42) THRBRORCCSNK2A1
SCHEMBL21483743 0.78 THRB (0.40) THRBRORCMAPTTHRAPPARA
SCHEMBL2388964 0.77 MAPT (0.50) THRBRORCGAAMEN1KMT2A
SCHEMBL19088279 0.76 GAA (0.42) RORCCSNK2A1GAALMNAALDH1A1
SCHEMBL2491543 0.76 CYP4F2 (0.36) THRBRORCMAPTACHEGRIN2D
SCHEMBL3722004 0.76 CSNK2A1 (0.70) THRBRORCCSNK2A1GAAMEN1
SCHEMBL18583495 0.74 CSNK2A1 (0.36) RORCCSNK2A1GAAMEN1KMT2A
SCHEMBL807271 0.74 THRB (0.44) THRBRORCCSNK2A1LMNAKDM4E
SCHEMBL10088548 0.73 S1PR1 (0.42) RORCCSNK2A1
SCHEMBL5107914 0.72 GRIN2D (0.55) THRBRORCGAAKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178735-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF ASTELLAS PHARMA INC. (JP) 2012-07-12 US disclosed
US-8193378-B2 2H-chromene compound and derivative thereof ASTELLAS PHARMA INC. (JP) 2012-06-05 US disclosed
US-20110230463-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF ASTELLAS PHARMA INC. (JP) 2011-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230463-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF S1PR1, S1PR2, CCR1 THRB 996/4885RORC 249/4885CSNK2A1 2025/4885
US-20120178735-A1 2H-CHROMENE COMPOUND AND DERIVATIVE THEREOF S1PR1, S1PR2, S1PR4 THRB 773/4885RORC 136/4885CSNK2A1 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.